These Two Firms Are Driving a Surge in Health Sector Securities Class Actions

, New York Law Journal


Securities lawsuits have become a major headache for life sciences companies, according to recent reports. And two plaintiffs' firms, Pomerantz and The Rosen Law Firm, are leading the charge.

This premium content is reserved for New York Law Journal subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

  • Darren McKinney, American Tort Reform Association, Washington, D.C.

    What, beyond further enriching scheming plaintiffs‘ lawyers and driving health care costs -- including drug prices -- higher for everyone else does this parasitic litigation accomplish? Certainly it‘s of no benefit to shareholders.

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202786216210

Thank you!

This article's comments will be reviewed.